Company Filing History:
Years Active: 1992-1994
Title: Mikkel Thaning: Innovator in Pharmaceutical Compounds
Introduction
Mikkel Thaning is a notable inventor based in Hjarup, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as calcium channel blockers. With a total of 3 patents, Thaning's work has the potential to impact various medical treatments.
Latest Patents
Thaning's latest patents include innovative compounds such as benzimidazole compounds useful as calcium channel blockers. This invention discloses compounds of the formula wherein R' and R' independently of each other are hydrogen or alkyl, or R' and R' together form a 3 to 6 membered alkylene chain. Another significant patent is related to imidazole compounds and their use. This application discloses benzimidazole derivatives, pharmaceutical preparations comprised of the compounds, their preparation, and use in the treatment of disorders of the Central Nervous System such as ischemia, migraine, epilepsia, psychosis, Parkinsonism, and depression.
Career Highlights
Mikkel Thaning is currently associated with Neurosearch A/S, a company focused on innovative pharmaceutical solutions. His work at Neurosearch has allowed him to explore and develop new therapeutic compounds that address critical health issues.
Collaborations
Thaning has collaborated with notable colleagues in his field, including Peter Moldt and Oskar Axelsson. These collaborations have contributed to the advancement of research and development in pharmaceutical innovations.
Conclusion
Mikkel Thaning's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.